Galaxy Diagnostics
Research Triangle Park, US · North Carolina corporation · 2 known investors
Biotech
Founders & leadership
AE
Amanda ElamExecutive Officer, Director
EB
Edward BreitschwerdtDirector
BJ
B. Jefferson ClarkExecutive Officer, Director
NB
Nicole BellExecutive Officer, Director
RW
Richard WestDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$3MraisedJun 2026 · 45 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2026 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amanda ElamDirector
- Joel KimbroughDirector
- Nicole BellExecutive Officer, Director
- Edward BreitschwerdtDirector
- B. Jefferson ClarkExecutive Officer, Director
- Richard WestDirector
- Offering amount
- $5.7M
- Amount sold
- $3M
- First sale
- May 2026
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$4.1MraisedApr 2025 · 55 investors · BiotechnologyRule 506(b)
▶$4.1MraisedApr 2025 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward BreitschwerdtDirector
- Amanda ElamExecutive Officer, Director
- Joel KimbroughDirector
- Richard WestDirector
- Nicole BellExecutive Officer, Director
- B. Jefferson ClarkExecutive Officer, Director
- Offering amount
- $11.2M
- Amount sold
- $4.1M
- First sale
- Apr 2025
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
▶$2MraisedJul 2024 · 27 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2024 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amanda ElamExecutive Officer, Director
- B. Jefferson ClarkExecutive Officer, Director
- Nicole BellExecutive Officer, Director
- Edward BreitschwerdtDirector
- Richard WestDirector
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Aug 2023
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
